Guideline-Directed Medical Therapy Assessment in Heart Failure Patients Undergoing Percutaneous Mitral Valve Repair
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14705 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Karl-Patrik Kresoja und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center of Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Heart Failure, Mitral Valve Insufficiency, Stroke Volume, Mitral Valve. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Center Mainz of the Johannes Gutenberg University Mainz.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Achieving optimized guideline-directed medical therapy (GDMT) is recommended prior to transcatheter mitral valve edge-to-edge repair (M-TEER) for secondary mitral regurgitation (SMR). We aimed to propose and validate an easy-to-use score for assessing the quality of GDMT in patients with heart failure with reduced ejection fraction (HFrEF) undergoing M-TEER. Methods and results Among the 1641 EuroSMR patients enrolled in the EuroSMR Registry who underwent M-TEER, a total of 1072 patients [median age 74, interquartile range (IQR) 67–79 years, 29% female] had complete data on GDMT and a left ventricular ejection fraction ≤ 40% and were included in the current study. We proposed a GDMT score that considers the dosage levels of three medication classes (angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor-neprilysin inhibitors, beta-blockers, and mineralocorticoid receptor antagonists), with a maximum score of 12 points indicating optimal GDMT. The primary outcome was all-cause mortality. The median GDMT score was 4 points (IQR 3–6). All three domains of the scoring system were associated with all-cause mortality (P < 0.05 for all). The overall GDMT score was associated with all-cause mortality (hazard ratio 0.90, 95% confidence interval 0.86–0.95 for each 1-point increase in the GDMT score). This association remained significant after adjusting for renal function and co-morbidities.
Conclusions
This study demonstrates the utility of a simple GDMT scoring system for assessing the adequacy of GDMT in HFrEF patients with relevant SMR undergoing M-TEER. The GDMT score has potential applications in guiding the design of future clinical trials and aiding clinical decision-making processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Medical Center of Mainz, Mainz, Germany.
- Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Strümpellstraße 39, Leipzig, 04289, Germany.
- Cardiac Catheterization Laboratory and Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
- Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
- Department of Cardiology, European Hospital Georges Pompidou and Paris Cardiovascular Research Center, INSERM U970, Paris, France.
- Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
ORCID-Profile: Karl-Patrik Kresoja
Förderung
- University Medical Center Mainz of the Johannes Gutenberg University Mainz
Zitieren
APA
Kresoja, K. P., Adamo, M., Rommel, K. P., Stolz, L., Karam, N., Giannini, C., Melica, B., von Bardeleben, R. S., Butter, C., Horn, P., Praz, F., Kalbacher, D., Iliadis, C., Thiele, H., Hausleiter, J., Metra, M., & Lurz, P. (2024). Guideline-Directed Medical Therapy Assessment in Heart Failure Patients Undergoing Percutaneous Mitral Valve Repair. ESC Heart Failure. https://doi.org/10.1002/ehf2.14705
Vancouver
Kresoja KP, Adamo M, Rommel KP, Stolz L, Karam N, Giannini C, et al. Guideline-Directed Medical Therapy Assessment in Heart Failure Patients Undergoing Percutaneous Mitral Valve Repair. ESC Heart Failure. 2024. doi:10.1002/ehf2.14705
BibTeX
@article{Kresoja2024,
author = {Kresoja, Karl-Patrik and Adamo, Marianna and Rommel, Karl-Phillipp and Stolz, Lukas and Karam, Nicole and Giannini, Cristina and Melica, Bruno and von Bardeleben, Ralph Stephan and Butter, Christian and Horn, Patrick and Praz, Fabien and Kalbacher, Daniel and Iliadis, Christos and Thiele, Holger and Hausleiter, Jörg and Metra, Marco and Lurz, Philipp},
title = {Guideline-Directed Medical Therapy Assessment in Heart Failure Patients Undergoing Percutaneous Mitral Valve Repair},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14705}
}
EUVIMED